Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Effects of triamcinolone acetonide on adult human lung fibroblasts: decrease in proliferation, surface molecule

S Oddera1, F Cagnoni, S Mangraviti

  • 1Allergy and Respiratory Diseases Service, University of Genoa, Genoa, Italy.

International Archives of Allergy and Immunology
|October 31, 2002
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reconsidering biologic treatment recommendations for CRSwNP without asthma in EUFOREA guidelines.

Rhinology·2026
Same author

PHARMACOGENETIC MARKERS IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA THERAPY.

Experimental oncology·2026
Same author

Genetic characteristics of the isolate of human adenovirus type 55 (<i>Adenoviridae: Mastadenovirus</i>) isolated in Moscow in 2022.

Voprosy virusologii·2025
Same author

Efficacy of 5-Grass Pollen Liquid Sublingual Allergen Immunotherapy for Seasonal Allergic Rhinoconjunctivitis: A Systematic Review and Meta-analysis.

Journal of investigational allergology & clinical immunology·2025
Same author

The Parameters of Long-Term Humoral Immunity Induced by a Single Injection of the Sputnik Light Vaccine Among Noninfected Volunteers and Those Infected with SARS-CoV-2.

Acta naturae·2025
Same author

Reply to Correspondence: The Bronchodilator and Anti-Inflammatory Effect of Long-Acting Muscarinic Antagonists in Asthma: An EAACI Position Paper.

Allergy·2025

Triamcinolone acetonide (TAA) inhibits lung fibroblast proliferation and reduces inflammatory mediators like IL-6 and IL-8. This suggests TAA has direct anti-inflammatory effects by suppressing resident lung cell function in airway inflammation.

Area of Science:

  • Pulmonology
  • Cell Biology
  • Pharmacology

Background:

  • Lung fibroblasts play a key role in airway inflammation through mediator secretion, proliferation, and interaction with inflammatory cells.
  • Fibroblasts are potential therapeutic targets for asthma treatments due to their involvement in inflammatory networks.

Purpose of the Study:

  • To investigate the effects of triamcinolone acetonide (TAA) on primary human lung fibroblasts.
  • To evaluate TAA's impact on fibroblast proliferation, extracellular matrix (ECM) release, cytokine/chemokine secretion, and surface antigen expression.

Main Methods:

  • In vitro study using primary human lung fibroblasts.
  • Exposure to increasing concentrations of TAA (10^-9 to 10^-7 M).
  • Assessment of proliferation, ECM release, cytokine/chemokine secretion (IL-6, IL-8), and surface antigen expression (VCAM-1, CD54) under various conditions (FCS, FGF, IFN-gamma, TGF-beta 1).

Related Experiment Videos

Main Results:

  • TAA decreased fetal calf serum (FCS)-induced fibroblast proliferation.
  • TAA reduced IL-6 and IL-8 secretion at concentrations of 10^-8 and 10^-7 M.
  • TAA decreased VCAM-1 expression in the presence of IFN-gamma and CD54 expression in TGF-beta 1-driven cultures.

Conclusions:

  • TAA modulates functional properties of human lung fibroblasts, impacting their role in airway inflammation.
  • TAA's inhibition of fibroblast proliferation may help reverse airway remodeling in chronic inflammatory diseases.
  • TAA demonstrates a direct anti-inflammatory effect by suppressing lung fibroblast function, indicated by reduced cytokine and surface molecule expression.